CatalogResearchCommunityTools
Research & Educational Use Only. This protocol guide is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional before beginning any research protocol.
Tanning / Photoprotection PeptideEvidence Grade: B- (Human Data, Unregulated)

Melanotan II Protocol Guide

Melanotan II (MT-2) is a synthetic analog of alpha-melanocyte stimulating hormone (a-MSH) that stimulates melanogenesis, the process by which melanin pigment is produced in skin cells. It activates melanocortin receptors (primarily MC1R) to promote UV-free tanning and is studied for photoprotective applications. Melanotan II also affects MC3R and MC4R, which can influence appetite suppression and sexual function. This protocol covers reconstitution from a 10mg vial with 2mL bacteriostatic water, subcutaneous dosing at 250mcg 3x/week during loading phase, transition to maintenance dosing, and safety monitoring including mole surveillance.

Protocol Overview

Compound
Melanotan II (MT-2, Alpha-MSH Analog)
Category
Tanning / Photoprotection Peptide
Mechanism
Activates melanocortin receptors (MC1R, MC3R, MC4R) to stimulate melanin production in melanocytes; also affects appetite and sexual function
Structure
Cyclic heptapeptide, synthetic a-MSH analog
Half-Life
~30-60 minutes
Vial Size
10mg lyophilized powder
Route
Subcutaneous injection
Frequency
3x/week (loading), 1x/week (maintenance)
Cycle Length
4-6 weeks loading, then maintenance

Dosing Protocol

PhaseDoseFrequencyRouteDuration
Initial Tolerance100-150 mcg3x/week (evening)SubcutaneousFirst 2-3 doses
Loading Phase250 mcg3x/week (Mon/Wed/Fri)Subcutaneous4-6 weeks
Maintenance250 mcg1x/week or biweeklySubcutaneousAs needed

Key principle: Start with low doses to assess tolerance and minimize nausea. Administer in the evening as nausea and flushing are most pronounced in the first hour. Some UV exposure is beneficial during loading phase to activate melanocytes that Melanotan II is priming.

Reconstitution Instructions

Materials Needed

  • Melanotan II 10mg lyophilized vial
  • Bacteriostatic water (2mL)
  • 3mL mixing syringe (18-20ga)
  • Insulin syringes (29-31ga) for dosing
  • Alcohol swabs

Reconstitution Steps

  1. Clean vial stopper with alcohol
  2. Draw 2mL bacteriostatic water
  3. Inject slowly down the vial wall
  4. Gently swirl (never shake)
  5. Wait 5 minutes for full dissolution
  6. Concentration: 5,000 mcg/mL
DoseVolume (2mL recon)Insulin Syringe
100 mcg0.02 mL2 units
250 mcg0.05 mL5 units
500 mcg0.10 mL10 units
1000 mcg0.20 mL20 units

Administration Guide

Injection Sites

  • Abdomen: Primary site, subcutaneous
  • Thigh: Outer thigh, alternate sides
  • Upper arm: Back of arm, alternate

Timing & Storage

  • Timing: Evening administration (nausea peaks ~30 min post-dose)
  • UV exposure: Brief sun exposure during loading helps activate melanocytes
  • Vial duration: ~67 days at 250mcg 3x/week
  • Storage (reconstituted): Refrigerate 2-8°C, use within 30 days
  • Do not freeze reconstituted solution

Expected Timeline

Day 1-3
Nausea and facial flushing common with first doses. Some subjects notice appetite suppression. No visible pigmentation changes yet.
Week 1-2
Side effects typically diminish as tolerance develops. Early freckling or slight darkening may appear, especially in sun-exposed areas.
Week 3-4
Noticeable tan developing. Existing moles may darken. Pigmentation changes becoming apparent even without significant sun exposure.
Week 5-6+
Full loading phase results. Significant melanin increase. Transition to maintenance dosing to retain pigmentation with minimal ongoing use.

Side Effects & Monitoring

Common Side Effects

  • Nausea (most common, especially early doses)
  • Facial flushing and warmth
  • Darkening of existing moles and freckles
  • Appetite suppression
  • Spontaneous erections (males)
  • Injection site redness

Nausea typically resolves after 3-5 doses as tolerance develops. Taking an antihistamine 30 min before injection can reduce flushing.

Precautions

  • Monitor all moles for changes in shape, size, or color
  • Regular dermatological skin checks recommended
  • Not approved by any regulatory agency for human use
  • MC4R activation may cause cardiovascular effects
  • Not recommended during pregnancy or breastfeeding
  • Subjects with melanoma history should avoid use

Stacking Recommendations

Compatible Compounds

  • GHK-Cu: Skin repair and collagen support
  • BPC-157: Tissue healing and skin health
  • Glutathione: Antioxidant support during melanogenesis
  • AOD-9604: Body composition support

Popular Stacks

  • Skin Health: Melanotan II + GHK-Cu for tan + collagen
  • Body Comp: Melanotan II (appetite suppression) + AOD-9604
  • Protective: Melanotan II + oral Glutathione

Blood Work Recommendations

PanelMarkersTiming
Basic PanelCBC, CMPBaseline, Week 6
Liver FunctionALT, AST, GGTBaseline, Week 6
HormonesBlood pressure, heart rate monitoringOngoing
DermatologyFull skin/mole checkBaseline, every 3 months

Dermatological monitoring is the most important safety measure with Melanotan II. Document all moles at baseline and track any changes in size, shape, color, or border irregularity.

★ OFFICIAL SPONSOR
BioRoot AI
Free Functional Assessment
AI-powered root cause analysis & care plan
Start Free
Paid partnership · Learn more

Related Resources

Oxytocin Protocol PT-141 Protocol Bremelanotide Protocol Dosing Calculator Reconstitution Calculator Bloodwork Planner Stack Checker Peptide Catalog
Share & Save
𝕏 Share on Twitter 📱 Share on Reddit 💬 WhatsApp ✉️ Email 🔗 Copy Link 🖨️ Print / Save PDF Save to Favorites